Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 1,039.08 | 461.98 | 238.22¢ | 2.8 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 497.75 | 55.52 | 19.00¢ | 35.5 | n/a | -92% | n/a | 0.0% |
31-Dec-27 | 271.80 | (6.19) | (31.63)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Local Digest | 10-May-2009 | Washington Post |
Novavax Moves Closer to Licensing Bird Flu Vaccine | 27-Aug-2008 | Washington Post |
Business Briefing | 09-Aug-2008 | Washington Post |
Currency | US Dollars |
Share Price | $ 6.75 |
Change Today | $ 0.19 |
% Change | 2.90 % |
52 Week High | $14.68 |
52 Week Low | $5.39 |
Volume | 4,154,692 |
Shares Issued | 23.47m |
Market Cap | $158.44m |
RiskGrade | 720 |
Strong Buy | 2 |
Buy | 2 |
Neutral | 2 |
Sell | 1 |
Strong Sell | 1 |
Total | 8 |
Time | Volume / Share Price |
16:00 | 288,020 @ $6.75 |
15:59 | 100 @ $6.76 |
15:59 | 100 @ $6.76 |
15:59 | 200 @ $6.76 |
15:59 | 1,000 @ $6.76 |
You are here: research